Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Uterine Cervical Neoplasms 3Vulvar Neoplasms 1Vaginal Neoplasms 1Penile Neoplasms 1Oropharyngeal Neoplasms 1Head and Neck Neoplasms 1Colonic Neoplasms 1Camurati-Engelmann Syndrome 1Anus Neoplasms 1

Interventions

pembrolizumab 8Oxaliplatin 7Surveys and Questionnaires 5Methods 5Early Intervention, Educational 5Cyclophosphamide 5Cisplatin 5Paclitaxel 4Magnetic Resonance Spectroscopy 4Leucovorin 4Gemcitabine 4Fluorouracil 4Carboplatin 4veliparib 3aldesleukin 3Trastuzumab 3Specimen Handling 3Nivolumab 3Diathermy 3Cytoreduction Surgical Procedures 3sargramostim 2entinostat 2cemiplimab 2cediranib 2X-Rays 2Therapeutics 2Radiotherapy 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Metformin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × bintrafusp alfa protein, human × Gynecologic × Clear all
NCT04708470 2026-04-06

A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
55 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡